Nostrum Laboratories Extended-release Metformin Recalled Due to N- nitrosodimethylamine (NDMA) Contamination
Posted: November 14, 2020 According to cardiovascularbusiness.com[1], the FDA[2] announced one more recall of extended-release (ER) metformin. Nostrum Laboratories’ metformin was recalled due to an unacceptable level of N-nitrosodimethylamine (NDMA). N-nitrosodimethylamine (NDMA) is a known carcinogen. Nostrum Laboratories, a medication manufacturer, based in Kansas City, Missouri, announced the recall this week. Nostrum Laboratories is recalling two lots of their ER metformin tablets. According...